BANK OF AMERICA CORPORATION (BAC) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Bank of America Corporation Investors of Upcoming Deadline

A securities fraud class action lawsuit has been commenced against Bank of America, with a December 15, 2026 deadline highlighted for investors. The notice does not provide allegations, potential damages, or any new financial impact on the company.

Analysis

This is an investor-rights solicitation, not a finding of wrongdoing or evidence that Bank of America’s expected cash flows have changed. With no allegations, class period, claimed damages, or procedural developments supplied, the notice alone does not support a fundamental re-rating of BAC. The near-term risk is mainly headline-driven volatility; the December deadline is not, by itself, a reliable catalyst for a material company-level outcome. Over the next 1–3 months, reassess only if court filings surface specific alleged control or disclosure failures, a credible damages estimate, or parallel regulatory action. Over 6–18 months, any effect would depend on litigation surviving dismissal and ultimately producing material damages, remediation costs, or changes to controls—not on the existence of a complaint alone. A sector-wide read-through to other large banks is unwarranted absent evidence of shared conduct. The key uncertainty is the missing case detail; do not infer liability or financial exposure from the law firm’s promotional notice.

Key Decisions for Investors

• No standalone directional trade in BAC on this notice; treat it as low-information headline risk rather than a change to earnings or valuation assumptions.
• Monitor the complaint, docket activity, and BAC filings for the alleged statements, relevant period, damages methodology, dismissal motions, and any regulatory overlap before sizing exposure.
• If BAC underperforms peers on subsequent litigation-specific news, distinguish company-specific repricing from broader bank-sector moves before adding or hedging risk.
• Falsify a benign-impact view if court or regulatory developments establish a credible path to material financial exposure or if BAC revises guidance or disclosures in response; absent that, avoid treating the deadline as a fundamental catalyst.